Boardroom Alpha
Meeting calendar
TW · Annual meeting · Tuesday, May 19, 2026

Tradeweb Markets Inc

3 nominees · 5 ballot items.

Election of three Class I directors; Ratification of Deloitte as independent auditors; Advisory approval of named executive officer compensation (say-on-pay); Approval of Exculpation Amendment to limit officers’ monetary liability under Delaware law and make clarifying changes to the Certificate of Incorporation; Approval of Federal Forum Selection Amendment to add an exclusive Securities Act federal forum provision.

Market cap
$23.3B
1Y TSR
-27.8%
Board grade
C-
Record date
Mar 20, 2026
Filing
DEF 14A
Meeting concluded · May 19, 2026

Follow how the vote landed and what changed on Tradeweb Markets Inc’s board — director track records, governance grades, and ongoing monitoring — on the Boardroom Alpha platform.

Proposals

On the ballot5

  1. 1

    Election of Directors

    ManagementBoard: FOR

    To elect three Class I director nominees (Scott Ganeles, Catherine Johnson and Daniel Maguire) each for a three-year term expiring in 2029.

  2. 2

    Ratification of Auditor (Deloitte & Touche LLP

    ManagementBoard: FOR

    To ratify the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026.

  3. 3

    Advisory Vote on Executive Compensation (Say-on-Pay

    ManagementBoard: FOR

    Non-binding advisory vote to approve the compensation paid to the named executive officers as disclosed in the proxy statement.

  4. 4

    Exculpation Amendment

    ManagementBoard: FOR

    Amend the Certificate of Incorporation to limit monetary liability of certain officers as permitted by Section 102(b)(7) of the Delaware General Corporation Law and make clarifying technical changes.

    More detail

    The Exculpation Amendment asks shareholders to approve an amendment to the Company’s Certificate of Incorporation to add statutory exculpation for certain officers to the same degree directors are exculpated under Delaware law, specifically Section 102(b)(7) of the DGCL. Management seeks approval to limit monetary liability of specified ‘covered officers’—including C-suite roles and those identified as most highly compensated or consented to in writing for service of process—solely with respect to direct claims for breach of the fiduciary duty of care brought by stockholders, while preserving liability for claims brought by the Company, derivative claims, duty of loyalty breaches, bad faith or intentional misconduct, knowing violations of law, or transactions involving improper personal benefit. The proposal also makes technical clarifications related to recent DGCL amendments (notably Section 242(d)) regarding authorized share capital adjustments. Management argues this amendment is narrowly tailored, aligned with a statutory change, and intended to enhance the Company’s ability to attract and retain experienced executives and reduce litigation distraction and costs. The Board unanimously recommends a “FOR” vote, noting the amendment’s limited scope and safeguards; key counterarguments include concerns about reducing accountability for officers and potential diminution of stockholder remedies in care-based claims. In evaluating this proposal, analysts should weigh the narrow statutory carve-out being requested, the high bar preserved for disallowing exculpation (e.g., loyalty and bad faith exceptions), the company’s existing governance structure and majority-controlling stockholder dynamics, and whether insulating officers from care-based liability materially changes executives’ risk calculus or stockholder protections. Given the company’s controlled status and LSEG’s continued influence, it is also relevant to consider how exculpation might interact with related-party governance and whether it materially shifts litigation risk or CEO/officer incentives. Overall, the Board’s rationale for competitiveness in hiring and retention is credible, but the change reduces a narrow category of officer accountability and should be weighed against the company’s already protective governance arrangements and the continued availability of remedies for more culpable misconduct.

  5. 5

    Federal Forum Selection Amendment

    ManagementBoard: FOR

    Amend the Certificate of Incorporation to add an exclusive federal forum selection clause for Securities Act claims, directing Securities Act claims to U.S. federal district courts and making related clarifying changes to the Delaware forum selection provision.

    More detail

    The Federal Forum Selection Amendment requests shareholder approval to amend the Certificate of Incorporation to designate U.S. federal district courts as the exclusive forum for claims arising under the Securities Act. Management’s rationale is to prevent forum shopping, avoid parallel litigation in state and federal courts, reduce duplication and inconsistent rulings, and utilize federal courts’ experience with Securities Act claims. The amendment also clarifies and reorganizes the existing Delaware forum provisions, specifying that other internal affairs and fiduciary claims remain subject to Delaware courts while separating Securities Act claims into the federal forum clause. The board recommends a “FOR” vote, citing prospective litigation efficiency and predictability. Analysts evaluating the proposal should weigh the benefits of reduced multi-forum litigation costs and predictable procedural outcomes against potential stockholder concerns regarding access to state courts, judicial forum choice limitations, and how the provision may affect plaintiffs’ ability to bring suits in certain favorable jurisdictions. Considerations include the company’s national shareholder base, the permissiveness of federal venue selection, and whether similar provisions are customary among peer companies; overall, federal forum clauses are increasingly common and courts have generally upheld them in many contexts, but outcomes may vary by jurisdiction and the precise wording of the clause.

Director elections

Nominees on the ballot3

Ownership

Top institutional holders10

Latest 13F quarter
1PRICE T ROWE ASSOCIATES INC /MD/6.3%14,819,970$1.7B
2WELLINGTON MANAGEMENT GROUP LLP2.7%6,477,614$762M
3VANGUARD PORTFOLIO MANAGEMENT LLC2.4%5,609,871$660M
4VANGUARD CAPITAL MANAGEMENT LLC2.2%5,190,795$611M
5T. Rowe Price Investment Management, Inc.1.4%3,398,763$400M
6AQR CAPITAL MANAGEMENT LLC1.2%2,846,984$335M
7BlackRock, Inc.1.2%2,835,498$334M
8Linonia Partnership LP1.2%2,791,246$328M
9STATE STREET CORP1.2%2,744,804$323M
10Grantham, Mayo, Van Otterloo Co. LLC1.1%2,650,663$312M
Filings

Recent key filings

Periodic reports
Definitive proxies
Reference

Frequently asked questions

When is the Tradeweb Markets Inc 2026 annual meeting?
Tradeweb Markets Inc (TW) holds its 2026 annual shareholder meeting on Tuesday, May 19, 2026.
What is the record date for the Tradeweb Markets Inc 2026 meeting?
The record date for the Tradeweb Markets Inc 2026 meeting is Friday, March 20, 2026. Shareholders of record on or before that date are eligible to vote.
Who are the director nominees for Tradeweb Markets Inc's 2026 meeting?
The board is presenting 3 director nominees at the Tradeweb Markets Inc 2026 meeting, listed with their independence status and background.
What proposals will shareholders vote on at the Tradeweb Markets Inc 2026 meeting?
Shareholders will vote on 5 proposals at the Tradeweb Markets Inc 2026 meeting, each tagged with who proposed it and the board's recommendation.
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer